Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemia
- 1 June 2016
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 29 (2) , 187-193
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12 482 persons from the National Health and Nutritional Examination SurveyLeukemia, 2014
- Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in SwedenBlood, 2014
- Toll-Like Receptor SignalingCold Spring Harbor Perspectives in Biology, 2013
- Progression in smoldering Waldenström macroglobulinemia: long-term resultsBlood, 2012
- Oncogenically active MYD88 mutations in human lymphomaNature, 2010
- Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myelomaLeukemia & Lymphoma, 2010
- Long-term survival in Waldenstrom macroglobulinemia: 10-year follow-up of Southwest Oncology Group–directed intergroup trial S9003Blood, 2009
- Waldenström macroglobulinaemiaBritish Journal of Haematology, 2007
- Prevalence of Monoclonal Gammopathy of Undetermined SignificanceNew England Journal of Medicine, 2006
- Long-term follow-up of IgM monoclonal gammopathy of undetermined significanceBlood, 2003